Skip to content

Oscar Health OSCR AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value

AFS and Trading Securities - Unrealized Loss Position (<12 Months) Fair Value at other companies

CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$4.6B+52.6%
Operating income$704.1M+137%
Net income$679.0M+147%
EPS (diluted)$2.07+125%

Balance sheet

See full
Cash & equivalents$4.8B+114%
Total debt$430.9M+43.7%
Total equity$1.7B+24.8%
Total assets$9.3B+59.0%

Cash flow

See full
Operating cash flow$2.6B+198%
CapEx$8.8M-2.6%
Free cash flow$2.6B+200%

Valuation

See full
Market cap$8.56B+4.0%
Enterprise value$4.16B-174%
P/S0.6×-0.2×

Profitability

See full
Operating margin0.1%
Net margin-0.3%
FCF margin-8.2%

Returns & leverage

See full
Return on equity-2.6%
Debt / equity0.3×0.0×
Current ratio1.1×+0.2×

Where this comes from

Reported directly by Oscar Health in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.

The official record: Oscar Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oscar Health's afs and trading securities - unrealized loss position (<12 months) fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oscar Health's AFS and trading securities - unrealized loss position (<12 months) fair value?
Oscar Health (OSCR) reported AFS and trading securities - unrealized loss position (<12 months) fair value of $1.04B in Q1 2026.
How has Oscar Health's AFS and trading securities - unrealized loss position (<12 months) fair value changed year-over-year?
Oscar Health's AFS and trading securities - unrealized loss position (<12 months) fair value increased by 62.2% year-over-year, from $641.56M to $1.04B.
What is the long-term trend for Oscar Health's AFS and trading securities - unrealized loss position (<12 months) fair value?
Over 3 years (2022 to 2025), Oscar Health's AFS and trading securities - unrealized loss position (<12 months) fair value has grown at a -21.7% compound annual growth rate (CAGR), from $724.61M to $347.68M.